Advances in technology for management of type 1 diabetes

• Published in: The Lancet (British edition) Vol. 394; no. 10205; pp. 1265 - 1273
• Main Authors: Beck, Roy W, Bergenstal, Richard M, Laffel, Lori M, Pickup, John C
• Format: Journal Article
• Language: English
• Published: London Elsevier Ltd 05.10.2019; Elsevier Limited
• Subjects: Algorithms; Automation; Blood glucose; Decision making; Diabetes; Diabetes mellitus; Diabetes mellitus (insulin dependent); Disease management; Endocrinology; Glucose; Glucose monitoring; Hypoglycemia; Insulin; Management; Meals; Measuring instruments; Quality of life; Sensors; England; Austria; United Kingdom > UK; United States > US; Germany; Wales
• ISSN: 0140-6736; 1474-547X; 1474-547X
• DOI: 10.1016/S0140-6736(19)31142-0

Technological advances have had a major effect on the management of type 1 diabetes. In addition to blood glucose meters, devices used by people with type 1 diabetes include insulin pumps, continuous glucose monitors, and, most recently, systems that combine both a pump and a monitor for algorithm-driven automation of insulin delivery. In the next 5 years, as many advances are expected in technology for the management of diabetes as there have been in the past 5 years, with improvements in continuous glucose monitoring and more available choices of systems that automate insulin delivery. Expansion of the use of technology will be needed beyond endocrinology practices to primary-care settings and broader populations of patients. Tools to support decision making will also need to be developed to help patients and health-care providers to use the output of these devices to optimise diabetes management.